PIONEER: A phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2

被引:45
作者
Albain, Kathy S. [1 ]
Belani, Chandra P.
Bonomi, Philip
O'Byrne, Kenneth J.
Schiller, Joan H.
Socinski, Mark
机构
[1] Loyola Univ, Chicago Med Ctr, Cardinal Bernadin Canc Ctr, Maywood, IL 60153 USA
[2] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15260 USA
[3] Rush Univ, Med Ctr, Chicago, IL 60612 USA
[4] St James Hosp, Dublin 8, Ireland
[5] Univ Texas, SW Med Ctr, Dallas, TX USA
[6] Univ N Carolina, Sch Med, Chapel Hill, NC USA
关键词
cathepsin B; estradiol; estrogen; lysosomal proteases; macromolecular drug conjugate;
D O I
10.3816/CLC.2006.n.027
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:417 / 419
页数:3
相关论文
共 28 条
[1]   SURVIVAL DETERMINANTS IN EXTENSIVE-STAGE NON-SMALL-CELL LUNG-CANCER - THE SOUTHWEST-ONCOLOGY-GROUP EXPERIENCE [J].
ALBAIN, KS ;
CROWLEY, JJ ;
LEBLANC, M ;
LIVINGSTON, RB .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (09) :1618-1626
[2]  
Balan K. V., 2001, Journal of Submicroscopic Cytology and Pathology, V33, P221
[3]   Epidermal growth factor receptor mutations and gene amplification in non-small-cell lung cancer: Molecular analysis of the IDEAL/INTACT gefitinib trials [J].
Bell, DW ;
Lynch, TJ ;
Haserlat, SM ;
Harris, PL ;
Okimoto, RA ;
Brannigan, BW ;
Sgroi, DC ;
Muir, B ;
Riemenschneider, MJ ;
Iacona, RB ;
Krebs, AD ;
Johnson, DH ;
Giaccone, G ;
Herbst, RS ;
Manegold, C ;
Fukuoka, M ;
Kris, MG ;
Baselga, J ;
Ochs, JS ;
Haber, DA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (31) :8081-8092
[4]   Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation [J].
Bunone, G ;
Briand, PA ;
Miksicek, RJ ;
Picard, D .
EMBO JOURNAL, 1996, 15 (09) :2174-2183
[5]   Lung cancer in women - Analysis of the national surveillance, epidemiology, and end results database [J].
Fu, JB ;
Kau, TY ;
Severson, RK ;
Kalemkerian, GP .
CHEST, 2005, 127 (03) :768-777
[6]   Macromolecular therapeutics - Advantages and prospects with special emphasis on solid tumour targeting [J].
Greish, K ;
Fang, J ;
Inutsuka, T ;
Nagamitsu, A ;
Maeda, H .
CLINICAL PHARMACOKINETICS, 2003, 42 (13) :1089-1105
[7]   Cancer statistics, 2005 [J].
Jemal, A ;
Murray, T ;
Ward, E ;
Samuels, A ;
Tiwari, RC ;
Ghafoor, A ;
Feuer, EJ ;
Thun, MJ .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (01) :10-30
[8]   ESTROGEN MODULATION OF OSTEOCLAST LYSOSOMAL-ENZYME SECRETION [J].
KREMER, M ;
JUDD, J ;
RIFKIN, B ;
AUSZMANN, J ;
OURSLER, MJ .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 57 (02) :271-279
[9]  
Langer CJ, 2005, J CLIN ONCOL, V23, p623S
[10]   Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: A large-scale population-based cohort study [J].
Liu, Y ;
Inoue, M ;
Sobue, T ;
Tsugane, S .
INTERNATIONAL JOURNAL OF CANCER, 2005, 117 (04) :662-666